Article
Biochemical Research Methods
Rui Qin, Guanmin Meng, Smruti Pushalkar, Michael A. Carlock, Ted M. Ross, Christine Vogel, Lara K. Mahal
Summary: Understanding the association between glycosylation and vaccine-induced antibody levels is crucial for improving vaccine design and vaccination strategies. A study on Caucasian adults receiving the FLUZONE influenza vaccine found that nonresponders had higher levels of Lewis A antigen (Lea) before vaccination. Glycoproteomic analysis suggested that glycosylation may play a role in modulating complement protein activities, which could be relevant to vaccine responses. Additionally, high responders showed an increase in sialyl Lewis X antigen (sLex) and a decrease in high mannose glycans after vaccination, indicating active modulation of glycosylation by the immune system.
JOURNAL OF PROTEOME RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Shaohuan Wu, Ted M. Ross, Michael A. Carlock, Elodie Ghedin, Hyungwon Choi, Christine Vogel
Summary: The study identifies determinants of influenza vaccine efficacy, with prior vaccination history, baseline titer level, and age being major factors. Other factors such as BMI, comorbidities, vaccine dose, and race have negligible effects. Models can accurately predict categorical responses in most cases, and generate a new seroconversion score corrected for these factors, facilitating future biomarker identification.
MOLECULAR SYSTEMS BIOLOGY
(2022)
Review
Virology
Xia Lin, Fangmei Lin, Tingting Liang, Mariette F. Ducatez, Mark Zanin, Sook-San Wong
Summary: This review highlights the issue of antibody non-responsiveness after influenza virus infection and vaccination, and discusses biological and technical factors that influence influenza antibody responses, with the aim of providing a more comprehensive understanding for improving influenza vaccines.
Article
Multidisciplinary Sciences
Rebecca K. Borchering, Christian E. Gunning, Deven Gokhale, K. Bodie Weedop, Arash Saeidpour, Tobias S. Brett, Pejman Rohani
Summary: The 2019/2020 influenza season in the United States started earlier than any season since the 2009 H1N1 pandemic, with influenza B cases dominating numerically in the early stages. The expansion of a new strain of influenza B may be associated with the shift in the season's composition and dynamics. Support was found for an increase in the effective reproduction number of influenza B, rather than cross-type immunity-driven dynamics, which has implications for vaccination strategies.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Immunology
Elene A. Clemens, Beth C. Holbrook, Masaru Kanekiyo, Jonathan W. Yewdell, Barney S. Graham, Martha A. Alexander-Miller
Summary: The study demonstrates that prime-boost vaccination with an influenza A virus vaccine conjugated with a TLR7/8 agonist (R848) can elicit antibody responses to the highly conserved hemagglutinin stem in newborns, rapidly inducing virus neutralizing stem-specific antibodies following viral challenge. This highlights the potential efficacy of R848 as an effective adjuvant for enhancing antibody responses in at-risk populations.
JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Rajeka Lazarus, Sarah Baos, Heike Cappel-Porter, Andrew Carson-Stevens, Madeleine Clout, Lucy Culliford, Stevan R. Emmett, Jonathan Garstang, Lukuman Gbadamoshi, Bassam Hallis, Rosie A. Harris, David Hutton, Nick Jacobsen, Katherine Joyce, Rachel Kaminski, Vincenzo Libri, Alex Middleditch, Liz McCullagh, Ed Moran, Adrian Phillipson, Elizabeth Price, John Ryan, Russell Thirard, Rachel Todd, Matthew D. Snape, David Tucker, Rachel Lauren Williams, Jonathan S. Nguyen-Van-Tam, Adam Finn, Chris A. Rogers
Summary: This study assessed the safety of concomitant administration of COVID-19 and influenza vaccines. The results showed that simultaneous vaccination with ChAdOx1 or BNT162b2 and an age-appropriate influenza vaccine raised no safety concerns and did not adversely affect immune responses.
Article
Microbiology
Marwa Abd Alhadi, Lilach M. Friedman, Erik A. Karlsson, Liel Cohen-Lavi, Anat Burkovitz, Stacey Schultz-Cherry, Terry L. Noah, Samuel S. Weir, Lester M. Shulman, Melinda A. Beck, Tomer Hertz
Summary: Obesity increases the risk of morbidity and mortality from influenza and SARS-CoV-2 infection. Previous studies have shown that influenza vaccines do not provide optimal protection in obese individuals. Our research reveals that obese individuals have differences in immune memory and a lower antibody response to influenza viruses. These findings have important implications for the development and usage of vaccines in obese individuals.
MICROBIOLOGY SPECTRUM
(2023)
Article
Multidisciplinary Sciences
Deven Gokhale, Tobias S. Brett, Biao He, Aaron A. King, Pejman Rohan
Summary: In the past two decades, countries with high vaccine coverage have experienced resurgent outbreaks of mumps, especially among those who have completed the recommended vaccination schedule. Possible reasons for vaccine failure include gradual waning of vaccine-derived immunity and the introduction of novel viral genotypes. Using statistical modeling based on age-structured epidemiological, demographic, and vaccine uptake data, it has been shown that the data supports the hypothesis of waning immunity. This study helps explain the shift in mumps incidence towards older individuals, the recurrence of outbreaks, and the high proportion of cases among vaccinated individuals.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2023)
Article
Immunology
Weijia Xiong, Tim K. Tsang, Ranawaka A. P. M. Perera, Nancy H. L. Leung, Vicky J. Fang, Ian G. Barr, J. S. Malik Peiris, Benjamin J. Cowling
Summary: We explored the biphasic pattern of antibody titers waning after influenza vaccination in children. Using blood samples, we found evidence for a faster waning in the first 1-2 years, followed by a slower decline in the longer term. Children with higher postvaccination titers showed faster antibody decay.
JOURNAL OF INFECTIOUS DISEASES
(2022)
Review
Immunology
Yo Han Jang, Baik L. Seong
Summary: Influenza virus infection poses a major public health challenge, with current vaccines potentially compromised by viral antigenic changes. Efforts are underway to develop a universal influenza vaccine that provides long-lasting and broad protection. Immune responses induced by live attenuated influenza vaccines (LAIVs), including neutralizing antibodies, T cell responses, and mucosal immunity, show promising potential for serving as attractive platforms for a universal influenza vaccine.
Article
Immunology
Kelly A. S. da Costa, Joanne Marie M. Del Rosario, Matteo Ferrari, Sneha Vishwanath, Benedikt Asbach, Rebecca Kinsley, Ralf Wagner, Jonathan L. Heeney, George W. Carnell, Nigel J. Temperton
Summary: By using NA pseudoviruses and developing the pELLA assay, we successfully measured neuraminidase inhibition levels in different influenza sera and found that pELLA is more sensitive than the commercially available NA-Fluor(TM). These studies may lead to the design of more potent, longer-lasting, and broader protective vaccines that can be used in a pre-pandemic approach in combination with HA vaccines.
Article
Immunology
Massimo Pieri, Eleonora Nicolai, Marco Ciotti, Marzia Nuccetelli, Serena Sarubbi, Martina Pelagalli, Sergio Bernardini
Summary: This study monitored workers during their vaccination program and found varying levels of antibodies produced after two doses of the vaccine. Individuals with previous natural infection had higher levels of antibodies. Among individuals with no history of infection, some had antibody levels similar to infected individuals, suggesting asymptomatic infection. For such individuals, a single dose of the vaccine may be sufficient to generate a protective immune response.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Review
Microbiology
Alvin X. Han, Simon P. J. de Jong, Colin A. Russell
Summary: This review summarizes the interplay between immunity evolution from previous infections or vaccination and the evolution of seasonal influenza viruses, including functional constraints, within-host evolutionary processes, and options for influenza virus control. It is found that seasonal influenza viruses continually evolve to escape host immunity, driven by viral constraints and host immune responses. However, it remains unclear how these advances can effectively reduce the impact of seasonal influenza on human health.
NATURE REVIEWS MICROBIOLOGY
(2023)
Article
Immunology
Ted. M. Ross, Naveen Gokanapudi, Pan Ge, Hua Shi, Robert A. Richardson, Spencer R. Pierce, Pedro Sanchez, Subhan Ullah, Eliana De Luca, Giuseppe A. Sautto
Summary: This study evaluated the antibody response associated with adjuvanted influenza vaccines, shedding light on the kinetics, magnitude, and subclass usage of antibody-secreting cells (ASCs) and circulating antigen-specific serum antibodies. The findings have important implications for improving the immune effectiveness of influenza vaccines.
Article
Microbiology
Kevin R. McCarthy, Jiwon Lee, Akiko Watanabe, Masayuki Kuraoka, Lindsey R. Robinson-McCarthy, George Georgiou, Garnett Kelsoe, Stephen C. Harrison
Summary: The study reveals a prevalent antibody response to a conserved region on the influenza virus HA, which has the potential to influence the outcomes of infection. These antibodies are genetically diverse and bind to HAs from multiple serotypes, making them valuable targets for immunogen design.
Article
Biochemistry & Molecular Biology
Jason D. Fernandes, Tyler B. Faust, Nicolas B. Strauli, Cynthia Smith, David C. Crosby, Robert L. Nakamura, Ryan D. Hernandez, Alan D. Frankel
Article
Biochemistry & Molecular Biology
Katharine A. White, Diego Garrido Ruiz, Zachary A. Szpiech, Nicolas B. Strauli, Ryan D. Hernandez, Matthew P. Jacobson, Diane L. Barber
Article
Biochemistry & Molecular Biology
Katharine A. White, Diego Garrido Ruiz, Zachary A. Szpiech, Nicolas B. Strauli, Ryan D. Hernandez, Matthew P. Jacobson, Diane L. Barber
Article
Cell Biology
Brian Biehs, Jimmy Kuang-Hsien Hu, Nicolas B. Strauli, Eugenio Sangiorgi, Heekyung Jung, Ralf-Peter Heber, Sunita Ho, Alice F. Goodwin, Jeremy S. Dasen, Mario R. Capecchi, Ophir D. Klein
NATURE CELL BIOLOGY
(2013)
Article
Multidisciplinary Sciences
Zachary A. Szpiech, Nicolas B. Strauli, Katharine A. White, Diego Garrido Ruiz, Matthew P. Jacobson, Diane L. Barber, Ryan D. Hernandez
Article
Virology
Greg Fedewa, Sheli R. Radoshitzky, Xiaoli Chi, Lian Dong, Xiankun Zeng, Melissa Spear, Nicolas Strauli, Melinda Ng, Kartik Chandran, Mark D. Stenglein, Ryan D. Hernandez, Peter B. Jahrling, Jens H. Kuhn, Joseph L. DeRisi
Article
Biotechnology & Applied Microbiology
Serghei Mangul, Harry Taegyun Yang, Nicolas Strauli, Franziska Gruhl, Hagit T. Porath, Kevin Hsieh, Linus Chen, Timothy Daley, Stephanie Christenson, Agata Wesolowska-Andersen, Roberto Spreafico, Cydney Rios, Celeste Eng, Andrew D. Smith, Ryan D. Hernandez, Roel A. Ophoff, Jose Rodriguez Santana, Erez Y. Levanon, Prescott G. Woodruff, Esteban Burchard, Max A. Seibold, Sagiv Shifman, Eleazar Eskin, Noah Zaitlen